
Overview
I am a general radiation oncologist who cares deeply about delivering high-quality cancer care in the community setting. Having grown up in a small town, I learned the value of great local doctors. I have a personal interest in brain tumors, breast, and prostate cancer.
Dr. Siglin is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Medulloblastoma, Vulvar Cancer, Breast Cancer, and Prostate Cancer.
His clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- POS
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3404 Wake Forest Rd, Raleigh, NC 27609
Additional Areas of Focus
Dr. Siglin has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Duke Blood Cancer Center
I was drawn to the field of oncology because cancer is a terrifying diagnosis for most people. It is one of those health issues that make people very nervous. I find great satisfaction working with cancer patients to help allay their fears and provide the best care possible. For me, it is rewarding to work with individuals who express so much courage in overcoming a difficult diagnosis. It is very rare that a patient comes alone to an appointment. Usually they have a spouse, son or daughter, a brother or sister, or a mother or father accompanying them. I spend a lot of time answering family member’s questions, who often provide a significant amount of care and support for their loved one. My job is to help educate both the patient and the family and to formulate a plan by which we can provide comprehensive care for all of the patient’s needs. Dr. Kelsey is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC).
Duke Cancer Center Radiation Oncology
I am a radiation oncologist, who specializes in treating head and neck and skin cancers. I chose this career path after watching an amazing friend receive treatment for a voice-box tumor. Her experience inspired me to dedicate my life to helping people like her. The relationships I develop with my patients, their families, and the clinical team are key to clinical success. By educating my patients about their cancers and treatment options, answering questions, and working together to develop a treatment plan, I empower my patients and provide the support they need to get through their treatments. I value being part of a skilled multidisciplinary team focused on providing compassionate and top-notched clinical care. I strive to constantly improve head and neck cancer treatments and am grateful to be able to offer cutting-edge clinical trials options to my patients. Outside of work, I treasure time with my family typically spent in outdoor activities including hiking, biking, camping, backpacking, running, kayaking, skiing, traveling, and playing/watching sports. We enjoy being active in the community and engaging in good causes. Dr. Robbins is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Laryngeal Cancer, Melanoma, Posterior Fossa Tumor, and Angiosarcoma.
Glenn Chrystal is a Radiation Oncologist in Burlington, North Carolina. Dr. Chrystal is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Breast Cancer, and Pleuropulmonary Blastoma. Dr. Chrystal is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- MedulloblastomaDr. Siglin isDistinguished. Learn about Medulloblastoma.
- Vulvar CancerDr. Siglin isDistinguished. Learn about Vulvar Cancer.
- Advanced
- AstrocytomaDr. Siglin isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Breast CancerDr. Siglin isAdvanced. Learn about Breast Cancer.
- Embryonal Tumor with Multilayered Rosettes
- EpendymomaDr. Siglin isAdvanced. Learn about Ependymoma.
- Familial Prostate CancerDr. Siglin isAdvanced. Learn about Familial Prostate Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Siglin isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Soft Tissue SarcomaDr. Siglin isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Siglin isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Siglin isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Siglin isExperienced. Learn about Angiosarcoma.


